title: Rarity of surgical complications after postchemotherapy nephrectomy for nephroblastoma. Experience of the International Society of Paediatric Oncology-Trial and Study "SIOP-9". International Society of Paediatric Oncology Nephroblastoma Trial and Study Committee.
abstract: The aim of the study was to assess rates and types of nephrectomy-related complications in children nephrectomized for nephroblastoma after preoperative chemotherapy. Records of 598 Wilms' tumour patients registered in the International Society of Paediatric Oncology Trial & Study No. 9 (SIOP-9), and pretreated correctly according to the protocol with vincristine + actinomycin D +/- epirubicine or adriamycin prior to nephrectomy, were retrospectively reviewed. Forty-nine patients (8%), who suffered from 54 complications, were identified. Most frequent events were small-bowel occlusions (3.7%) and tumour ruptures (2.8%). Other complications were registered in 2.0% of cases. The low rate of nephrectomy complications and no deaths related to registered ones, are another argument for preoperative chemotherapy in Wilms' tumour patients.
authors.affiliation: Department of Paediatric Surgery, Marciniak Hospital, Wrocław, Poland.
authors.forename: J
authors.initials: J
authors.lastname: Godzinski
authors.forename: M F
authors.initials: MF
authors.lastname: Tournade
authors.forename: J
authors.initials: J
authors.lastname: deKraker
authors.forename: J
authors.initials: J
authors.lastname: Lemerle
authors.forename: P A
authors.initials: PA
authors.lastname: Voute
authors.forename: A
authors.initials: A
authors.lastname: Weirich
authors.forename: R
authors.initials: R
authors.lastname: Ludwig
authors.forename: M
authors.initials: M
authors.lastname: Rapala
authors.forename: G
authors.initials: G
authors.lastname: Skotnicka
authors.forename: F
authors.initials: F
authors.lastname: Gauthier
authors.forename: C G
authors.initials: CG
authors.lastname: Moorman-Voestermans
authors.forename: D
authors.initials: D
authors.lastname: Buerger
authors.forename: A
authors.initials: A
authors.lastname: VanVeen
authors.forename: K
authors.initials: K
authors.lastname: Sawicz-Birkowska
mesh_terms: D000293:Adolescent; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D002648:Child; D002675:Child, Preschool; D003609:Dactinomycin / Q000627:therapeutic use; D005060:Europe; D006801:Humans; D007223:Infant; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000601:surgery*; D009392:Nephrectomy / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies; D014750:Vincristine / Q000627:therapeutic use; D009396:Wilms Tumor / Q000188:drug therapy / Q000601:surgery*
chemical_list: D000903:Antibiotics, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D003609:Dactinomycin; D014750:Vincristine